Investor'S Fiduciary Advisor Network, LLC Clearside Biomedical, Inc. Put Options Transaction History
Investor'S Fiduciary Advisor Network, LLC
- $269 Million
- Q2 2025
Put Options
0 transactions
| Quarter | Operation | Price Per put | puts change | puts Held | SEC Form |
|---|
Others Institutions Holding CLSD
# of Institutions
48Shares Held
11.8MCall Options Held
0Put Options Held
0-
Vanguard Group Inc Valley Forge, PA3.36MShares$1.45 Million0.0% of portfolio
-
Act Capital Management, LLC Wayne, PA2.2MShares$944,9163.43% of portfolio
-
Carmignac Gestion Paris, I01.51MShares$648,5870.02% of portfolio
-
Black Rock Inc. New York, NY798KShares$343,1980.0% of portfolio
-
Geode Capital Management, LLC Boston, MA790KShares$339,8600.0% of portfolio
About Clearside Biomedical, Inc.
- Ticker CLSD
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 60,190,700
- Market Cap $25.9M
- Description
- Clearside Biomedical, Inc., a biopharmaceutical company, focuses on the revolutionizing the delivery of therapies to the back of the eye through the suprachoroidal space. The company offers XIPERE, a triamcinolone acetonide suprachoroidal injectable suspension for the treatment of uveitis macular edema. It also develops CLS-AX, an axitinib injec...